Literature DB >> 28325815

Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression.

Giannina Descalzi1, Vasiliki Mitsi1, Immanuel Purushothaman1, Sevasti Gaspari1, Kleopatra Avrampou1, Yong-Hwee Eddie Loh1, Li Shen1, Venetia Zachariou2.   

Abstract

Neuropathic pain is a complex chronic condition characterized by various sensory, cognitive, and affective symptoms. A large percentage of patients with neuropathic pain are also afflicted with depression and anxiety disorders, a pattern that is also seen in animal models. Furthermore, clinical and preclinical studies indicate that chronic pain corresponds with adaptations in several brain networks involved in mood, motivation, and reward. Chronic stress is also a major risk factor for depression. We investigated whether chronic pain and stress affect similar molecular mechanisms and whether chronic pain can affect gene expression patterns that are involved in depression. Using two mouse models of neuropathic pain and depression [spared nerve injury (SNI) and chronic unpredictable stress (CUS)], we performed next-generation RNA sequencing and pathway analysis to monitor changes in gene expression in the nucleus accumbens (NAc), the medial prefrontal cortex (mPFC), and the periaqueductal gray (PAG). In addition to finding unique transcriptome profiles across these regions, we identified a substantial number of signaling pathway-associated genes with similar changes in expression in both SNI and CUS mice. Many of these genes have been implicated in depression, anxiety, and chronic pain in patients. Our study provides a resource of the changes in gene expression induced by long-term neuropathic pain in three distinct brain regions and reveals molecular connections between pain and chronic stress.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2017        PMID: 28325815      PMCID: PMC5524975          DOI: 10.1126/scisignal.aaj1549

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  167 in total

1.  LMTK3 deficiency causes pronounced locomotor hyperactivity and impairs endocytic trafficking.

Authors:  Takeshi Inoue; Naosuke Hoshina; Takanobu Nakazawa; Yuji Kiyama; Shizuka Kobayashi; Takaya Abe; Toshifumi Yamamoto; Toshiya Manabe; Tadashi Yamamoto
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

2.  Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour.

Authors:  E Nakamura; K Kadomatsu; S Yuasa; H Muramatsu; T Mamiya; T Nabeshima; Q W Fan; K Ishiguro; T Igakura; S Matsubara; T Kaname; M Horiba; H Saito; T Muramatsu
Journal:  Genes Cells       Date:  1998-12       Impact factor: 1.891

3.  Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Diana Meske; Chaoling Qu; Kozo Morimura; Alec Okun; Naohisa Arakawa; Michael Ossipov; Howard L Fields; Frank Porreca
Journal:  J Neurosci       Date:  2015-05-06       Impact factor: 6.167

4.  apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice.

Authors:  Jennifer Robertson; Justine Curley; Jeffrey Kaye; Joseph Quinn; Timothy Pfankuch; Jacob Raber
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

5.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

6.  Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens.

Authors:  Neil Schwartz; Paul Temkin; Sandra Jurado; Byung Kook Lim; Boris D Heifets; Jai S Polepalli; Robert C Malenka
Journal:  Science       Date:  2014-08-01       Impact factor: 47.728

Review 7.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

8.  Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits.

Authors:  Javeria A Hashmi; Marwan N Baliki; Lejian Huang; Alex T Baria; Souraya Torbey; Kristina M Hermann; Thomas J Schnitzer; A Vania Apkarian
Journal:  Brain       Date:  2013-09       Impact factor: 13.501

9.  Effects of antidepressant treatment on neuroactive steroids in major depression.

Authors:  E Romeo; A Ströhle; G Spalletta; F di Michele; B Hermann; F Holsboer; A Pasini; R Rupprecht
Journal:  Am J Psychiatry       Date:  1998-07       Impact factor: 18.112

10.  A mouse model of depression induced by repeated corticosterone injections.

Authors:  Yunan Zhao; Ru Ma; Jia Shen; Hui Su; Dongming Xing; Lijun Du
Journal:  Eur J Pharmacol       Date:  2007-12-14       Impact factor: 4.432

View more
  46 in total

1.  Reduced ΔFosB expression in the rat nucleus accumbens has causal role in the neuropathic pain phenotype.

Authors:  Sarah L Pollema-Mays; Maria Virginia Centeno; Zheng Chang; A Vania Apkarian; Marco Martina
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

2.  MBD1 Contributes to the Genesis of Acute Pain and Neuropathic Pain by Epigenetic Silencing of Oprm1 and Kcna2 Genes in Primary Sensory Neurons.

Authors:  Kai Mo; Shaogen Wu; Xiyao Gu; Ming Xiong; Weihua Cai; Fidelis E Atianjoh; Emily E Jobe; Xinyu Zhao; Wei-Feng Tu; Yuan-Xiang Tao
Journal:  J Neurosci       Date:  2018-09-28       Impact factor: 6.167

Review 3.  The Opioid Crisis and the Future of Addiction and Pain Therapeutics.

Authors:  Nathan P Coussens; G Sitta Sittampalam; Samantha G Jonson; Matthew D Hall; Heather E Gorby; Amir P Tamiz; Owen B McManus; Christian C Felder; Kurt Rasmussen
Journal:  J Pharmacol Exp Ther       Date:  2019-09-03       Impact factor: 4.030

4.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Authors:  Sevasti Gaspari; Immanuel Purushothaman; Valeria Cogliani; Farhana Sakloth; Rachael L Neve; David Howland; Robert H Ring; Elliott M Ross; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

Review 5.  The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.

Authors:  Randal A Serafini; Kerri D Pryce; Venetia Zachariou
Journal:  Biol Psychiatry       Date:  2020-01-01       Impact factor: 13.382

6.  Effects of resveratrol in the signaling of neuropathic pain involving P2X3 in the dorsal root ganglion of rats.

Authors:  Jinhui Guo; Chaowei Wang; Xiaolu Niu; Fang Zhou; Huiling Li; Weifang Gao
Journal:  Acta Neurol Belg       Date:  2019-04-15       Impact factor: 2.396

7.  RGS4 Maintains Chronic Pain Symptoms in Rodent Models.

Authors:  Kleopatra Avrampou; Kerri D Pryce; Aarthi Ramakrishnan; Farhana Sakloth; Sevasti Gaspari; Randal A Serafini; Vasiliki Mitsi; Claire Polizu; Cole Swartz; Barbara Ligas; Abigail Richards; Li Shen; Fiona B Carr; Venetia Zachariou
Journal:  J Neurosci       Date:  2019-07-15       Impact factor: 6.167

Review 8.  Looking beyond the intervertebral disc: the need for behavioral assays in models of discogenic pain.

Authors:  Grace E Mosley; Thomas W Evashwick-Rogler; Alon Lai; James C Iatridis
Journal:  Ann N Y Acad Sci       Date:  2017-08-10       Impact factor: 5.691

Review 9.  Resilience to Stress and Resilience to Pain: Lessons from Molecular Neurobiology and Genetics.

Authors:  Eric J Nestler; Stephen G Waxman
Journal:  Trends Mol Med       Date:  2020-04-18       Impact factor: 11.951

10.  Concentrations of oxidized linoleic acid derived lipid mediators in the amygdala and periaqueductal grey are reduced in a mouse model of chronic inflammatory pain.

Authors:  J R Jensen; M H Pitcher; Z X Yuan; C E Ramsden; A F Domenichiello
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-07-23       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.